Navigation Links
Experimental technique at GUMC offers real-time analysis of breast cancer biopsies
Date:11/13/2007

Washington, D.C. − A sophisticated microscope that offers a real-time 3-D analysis of tissue samples might, in the future, reduce the number of needle biopsies traditionally needed from women suspected of having breast cancer, according to recent research published at Georgetown University Medical Centers Lombardi Comprehensive Cancer Center.

Such an instant test would mean that physicians could immediately tell if they have collected adequate samples of breast tissue and limit the number of repeat biopsies, said the investigators, whose study appeared in the September/October issue of the Journal of Biomedical Optics.

Currently, physicians extract 6-8 tissue samples during a needle biopsy procedure to ensure proper sampling of the area of concern. In addition, at least one day is required to prepare the samples for analysis using traditional methods. The new technology is designed to limit patient discomfort and anxiety.

With this microscope, we can tell instantly whether we have cancer cells or not, or what kind of cells we are looking at, whether they are fat, structural, or epithelial cells that line breast milk ductsall of this could give us a great advantage in treating breast cancer, said the studys lead investigator, Maddalena T. Tilli, PhD, a postdoctoral fellow in the laboratory of Priscilla Furth, MD, at the Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center.

This tool could perhaps be used at the bedside to not only reduce the number of biopsies that we take from patients, but which could possibly be used during an operation to make sure surgeons have removed all cancerous tissue, said Furth, the studys senior investigator and a professor of oncology at Georgetown.

The technique is fairly simple. A reflectance confocal microscope reflects near-infrared light off multiple mirrors through tissue, then records the scattering of light. The idea behind this is that certai
'/>"/>

Contact: Becky Wexler
rjw43@georgetown.edu
202-687-5100
Georgetown University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
2. Experimental Antidepressants Offer Faster Relief
3. Experimental drug shows promise in advanced kidney cancer
4. Experimental drug boosts survival in recurrent ovarian cancer
5. Experimental cancer pharmaceuticals under trial
6. Experimental Drug Fails Against Heart Failure
7. Experimental Drug Fights Prostate Cancer
8. Eye-staining technique offers early detection for dry eye syndrome
9. New technique detects specific chromosomal damage, may indicate lung cancer risk
10. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
11. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...very preterm births more likely, British study fin...-- Pregnant women who are poor are more likely to ...en, even though both groups typically receive equa...sity of Leicester research team said their finding...n between economic status and preterm birth. , ...
(Date:12/1/2009)...RLEANS, Dec. 1 The Amer...ual High School Student Symposium at the New Orlea...CST. The symposium, which encourages an interest i... research, is held in conjunction with the Society...ave the opportunity to explore research on sickle ...
(Date:12/1/2009)...NGTON, Dec. 1 On Decemb... 1,538 federal prisoners were HIV positive or had ...BJS) in the Office of Justice Programs, U.S. Depar..., an estimated 5,672 inmates in state and federal ...7. In 2007, about 43 per 10,000 prison inmates wer...
(Date:12/1/2009)...ho would benefit from liver surgery after chemo, s...Day News) -- A CT scan of liver tumors caused by t...erall survival after chemotherapy, researchers rep...c chemotherapy has been shown to improve survival ...to produce better results in patients having surge...
(Date:12/1/2009)... Practitioners of any medical, legal or busines...ing a sigh of relief this week with the release of...on, released over the holiday weekend, allows anyo...ings to do so quickly and seamlessly using just th...WEB) December 1, 2009 -- The iPhone App, released ...
Breaking Medicine News(10 mins):Health News:More Preemies Born Among the Poor 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2
...rchers at the Genomics Institute of the Novartis R...compounds that can trigger the proliferation of i...isticated high-throughput screening techniques. ...the first study of its kind, and represents an imp...
...k factor is metabolic syndrome has distinct forms ...se findings are in the March issue of Hepatology ...lf of the American Association for the Study of Li...s hepatocellular carcinoma, is the fifth most comm...
... Spinal Association ( www.UnitedSpinal.org ) and i...First.org ), in partnership with Vietnam Veterans ...s Health Council ( www.veteranshealth.org ) at a ...onal forum for health care professionals, advocacy...
...in Diabetes Prevention and Management Among Most A...erck Company Foundation (Foundation), the philanth...d the launch of The Alliance to Reduce Disparities...n, Hispanic, and Native American adults. The U.S....
...rcent of Patients Select OTC Products Recommended ...hington, D.C. (Vocus) February 25, 2009 -- Accordi...ter Product Survey conducted by the American Phar...cist. With more than 100,000 nonprescription medic...
... Getaways ... Exclusive Couture Creations and Pack...ralysis , , BAL HARBOUR, Fla., Feb. 25 South Fl...ashion,s top designers and the highest concentrati...tion that kicks off on Thursday, February 26, be...
Other Medicine News:Health News:Compounds that trigger beta cell replication identified by JDRF funded researchers 2Health News:Liver tumors associated with metabolic syndrome differ from other tumors 2Health News:United Spinal Association Introduces The Veterans Health Council: Improving Veterans Health through Information and Advocacy 2Health News:United Spinal Association Introduces The Veterans Health Council: Improving Veterans Health through Information and Advocacy 3Health News:The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps 2Health News:The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps 3Health News:The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps 4Health News:The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps 5Health News:The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps 6Health News:Pharmacists Encourage Patients To Seek Their Guidance When Choosing OTC Medications 2Health News:Spectacular Ultra-Luxe Auction for Destination Fashion 2009, Presented by Stewart Rahr, Best of Bal Harbour's Brands Contribute More Than $250,000 Worth of Exclusive Items 2Health News:Spectacular Ultra-Luxe Auction for Destination Fashion 2009, Presented by Stewart Rahr, Best of Bal Harbour's Brands Contribute More Than $250,000 Worth of Exclusive Items 3Health News:Spectacular Ultra-Luxe Auction for Destination Fashion 2009, Presented by Stewart Rahr, Best of Bal Harbour's Brands Contribute More Than $250,000 Worth of Exclusive Items 4
(Date:12/1/2009)...re/ -- MedNet Solutions, a global life sciences te...l study management systems, today announced that ...al technology solution, has been certified by the ...ISC) as complying with the Operational Data Model ...dNet,s commitment to streamlining the entire clini...
(Date:12/1/2009)... 1 The educational resou...mproving Life," created by Lilly USA (NYSE: LLY ...om/value_of_medicine.jsp . The booklet supports Li..." and encourages an open dialogue with patients, p...al industry practices. ,, "Today, Lilly and ot...
(Date:12/1/2009)...re-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: D...ed to Chrono Nutraceuticals LLC exclusive rights i...ease dietary supplements using SCOLR,s proprietary...COLR granted Chrono rights to manufacture and sell...nexclusive basis. Chrono paid SCOLR $25,000 upon ...
Breaking Medicine Technology:MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 3Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 4SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3Caliper Life Sciences to Webcast Investor Session of Open House 12528 1Caliper Life Sciences to Webcast Investor Session of Open House 12528 2Toms of Maine Invites Public Participation in 50 States for Good Program 48207 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 2More Ontario children are getting diagnosed with diabetes 3A ICES study 48205 1
..., Calif., June 10 /PRNewswire-FirstCall/ - Neuroge...pany focused on developing and,commercializing nov...publication of Phase 3 data of its lead product ca...aper, titled, "Controlled Trial in,High-Concentrat...europathy," will appear in the June 10, 2008 editi...
...rial Results Expected in Q3 2008, Conference Call...astern Time, MOU..., Inc. (Nasdaq: ALXA ) announced today that it ha...al trial with AZ-004 (Staccato(R),loxapine). AZ-00...ed for,the treatment of acute agitation in patient...
Other Medicine Technology:NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 2NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 2Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 4Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 5Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 7
Reliavac® 400ccEvacuators & Kits
Reliavac® 100cc low suction evacuator kits with flat drains and Y-connector tubing
Bile Bags
Whelan-Moss T-Tube
Medicine Products: